烟台双塔食品股份有限公司 证券代码：002481 证券简称：双塔食品 编号：2025-081 烟台双塔食品股份有限公司 关于董事长部分股份解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 烟台双塔食品股份有限公司（以下简称"双塔食品"或"公司"）近日接到董 事长杨君敏先生通知，获悉其持有公司的部分股份办理了解除质押，具体事项如下： 一、本次解除质押基本情况 董 事 会 二〇二五年十二月十六日 | | 股股东或 第一大股 | 质押股份 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 是否为控 | 本次解除 | 占其所 | 占公司 | 是否 | | | | | 股东名称 | 东及其一 | 数量 | 持股份 | 总股本 | 为限 | 起始日期 | 解除日期 | 质权人 | | | | | 比例 | 比例 | 售股 | | | | | | 致行动人 | | | | | | | | | 杨君敏 | 否 | 26,000,000 | 17.20% | 2.11 ...

双塔食品公告称，近日董事长杨君敏持有公司的部分股份办理了解除质押。本次解除质押股份数量2600 万股，占其所持股份比例17.20%，占公司总股本比例2.11%，起始日期为2023年11月30日，解除日期为 2025年12月15日，质权人为招商证券股份有限公司。杨君敏持股1.51亿股，占比12.25%，累计质押6327 万股，占其所持股份比例41.86%。 ...

烟台双塔食品股份有限公司 | | | | 本次质 | 本次质 | 占其 | 占公司 | 已质押股份情况 | | 未质押股份情况 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 持股数量 | 持股 | 押前质 | 押后质 | 所持 | 总股本 | 已质押 | 占已质 | 未质押股 | 占未质 | | 名称 | | 比例 | 押股份 | 押股份 | 股份 | 比例 | 股份冻 | 押股份 | 份限售和 | 押股份 | | | | | 数量 | 数量 | 比例 | | 结数量 | 比例 | 冻结数量 | 比例 | | 杨君 | 151,160, | 12.25 | 70,530, | 89,270, | 59.06% | 7.24% | 0 | 0.0% | 0 | 0.0% | | 敏 | 633 | % | 000 | 000 | | | | | | | 证券代码：002481 证券简称：双塔食品 编号：2025-080 烟台双塔食品股份有限公司 关于董事长部分股份进行质押的公告 本公司及董事会全体成员 ...

Core Insights - The plant-based meat industry is gaining attention due to increasing consumer awareness of healthy eating and sustainability, with unique taste and nutritional value driving demand [1][9] - The market for plant-based meat in China saw a decline in 2022, with a 5.6% year-on-year decrease, but is expected to recover, reaching a market size of 10.5 billion yuan by 2025, a 10.5% increase [1][9] Industry Overview - Plant-based meat is made from plant proteins like soy and peas, mimicking the texture and flavor of animal meat, and offers health benefits such as zero cholesterol and high essential amino acids [1][3] - The industry has evolved through five stages, from early exploration (1970s-2008) to commercialization (2009-2018), explosive growth (2019-2021), a cooling adjustment period (2022-2024), and now a phase of transformation and standardized development [4][5][6] Market Dynamics - The global plant-based meat market is projected to grow from $12.1 billion in 2019 to $16.5 billion in 2024, with a compound annual growth rate (CAGR) of 6.4% driven by health and sustainability concerns [9] - In China, the market is expected to recover and grow, with companies diversifying their product offerings to adapt to local tastes and preferences [1][9] Competitive Landscape - Major players in the global market include Beyond Meat and Impossible Foods, while in China, companies like Yantai Shuangta Food Co., Ltd., Jinzi Ham Co., Ltd., and Shenzhen Qishan Food Co., Ltd. are key competitors [2][10] - Jinzi Ham has developed various plant-based products and was the first to sell plant-based meat in China, while Shuangta Food focuses on pea protein and has established a dedicated plant-based meat team [10][12] Development Trends - The industry is expanding into Chinese culinary contexts, with products like dumplings and hot pot meatballs emerging, while technological advancements are improving taste and texture [13] - A standardized labeling and safety framework is expected to enhance consumer trust and market growth, alongside a diversification of raw materials beyond soy and peas to include microalgae and yeast proteins [13][14]

证券代码：002481 证券简称：双塔食品 编号：2025-079 烟台双塔食品股份有限公司 关于泰国子公司生产线建成投产的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 登录新浪财经APP 搜索【信披】查看更多考评等级 泰国子公司生产线的投产将进一步增加公司产能、产品市场竞争力和盈利能力，同时对公司未来经营业 绩产生积极的影响，将进一步巩固公司行业优势地位。 目前泰国子公司处于初步投产阶段，全面达产尚需一定时间，项目产能的释放需要一个过程，也有可能 面临因市场需求环境变化、竞争加剧等因素的影响，敬请广大投资者关注并注意投资风险。 烟台双塔食品股份有限公司 董 事 会 二〇二五年十二月九日 烟台双塔食品股份有限公司（以下简称"公司"或"本公司"）于2024年5月14 日召开第六届董事会第七次 会议审议通过《关于对外投资设立控股子公司的议案》，公司全资子公司双塔食品（香港）有限公司在 泰国投资设立控股子公司，总投资额约3亿元人民币（或等额外币），包括设立泰国公司、购买土地、 工厂建设及设备采购等。 2025年8月19日第六届董事会第十四次会议审议通过了《关 ...

Group 1 - Rhein Biotech and Jia Mei Packaging's controlling shareholders are planning changes in company control, with trading suspension starting from December 10, 2025, for Rhein Biotech expected to last no more than 10 trading days and for Jia Mei Packaging no more than 2 trading days [1][2] - Rhein Biotech intends to acquire at least 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a combination of issuing shares and cash payment, which will make Beijing Jinkangpu a subsidiary included in the consolidated financial statements [1] - Jia Mei Packaging's controlling shareholder is also in discussions regarding a potential change in control, with specific transaction details still under negotiation [2] Group 2 - Haiguang Information has terminated its plan to merge with Zhongke Shuguang through a share exchange, as approved in a board meeting on December 9, 2025 [3] - Huatai Medical plans to repurchase shares with a total amount not less than RMB 200 million and not exceeding RMB 250 million, with a repurchase price cap of RMB 315 per share [4] - Songcheng Performing Arts and Jingu Co., Ltd. also announced share repurchase plans, with Songcheng aiming for a total of RMB 100 million to RMB 200 million and Jingu targeting RMB 30 million to RMB 60 million [4] Group 3 - Xiamen Airport is planning to acquire 100% of the shares of Zhaoxiang Technology, a wholly-owned subsidiary of its controlling shareholder, Xiamen Xiangye Group [5] - Borui Communication intends to acquire 51% of Meijing Technology from related parties for a total price of RMB 66.49 million [6] - Gu Ao Technology's actual controller is planning a change in control, with trading suspension starting from December 8, 2025, and expected to last no more than 3 trading days [6] Group 4 - ST Kevin's application to revoke the risk warning on its stock has been approved, with trading suspension for one day on December 10, 2025, and resuming trading on December 11, 2025 [6] - Huailun Crystal's stock will be suspended for one day starting December 10, 2025, due to false disclosures in its annual reports for 2021 and 2022 [7] - The stock of Jia Ao Environmental Protection will also be suspended for one day on December 10, 2025, due to an administrative penalty notice received from the regulatory authority [12] Group 5 - The company Yongmota plans to invest approximately RMB 400 million in a new project for magnesium-aluminum alloy components for the automotive and robotics industries [20] - ST Ningke is executing a capital reserve transfer plan to increase its share capital, with a total share increase from 684.88 million to 1.62 billion shares [21] - Yingpais plans to increase its shareholding through a combination of bank loans and self-funding, with a total investment of no less than RMB 60 million and no more than RMB 120 million [22]

Core Viewpoint - The company, Shuangta Food, has completed the construction and trial production of its production line in Thailand, which is expected to enhance its capacity, market competitiveness, and profitability, positively impacting its operational performance [1]. Group 1: Company Performance - As of December 9, 2025, Shuangta Food's stock closed at 5.72 yuan, up 0.35% from the previous trading day, with a total market capitalization of 7.057 billion yuan [1]. - The stock opened at 5.67 yuan, reached a high of 5.77 yuan, and a low of 5.56 yuan, with a trading volume of 1.75 billion yuan and a turnover rate of 2.76% [1]. Group 2: Project Development - The production line project in Thailand was initially approved on May 14, 2024, with an original total investment of approximately 300 million yuan [1]. - Due to factors such as tariffs, construction, equipment investment increases, and exchange rate fluctuations, the company decided to increase the investment to about 450 million yuan on August 19, 2025 [1]. - The announcement indicates that while the project will contribute positively to the company's performance, full production capacity will take time to achieve, and there are risks associated with market demand fluctuations [1].

Group 1 - Wanma Technology has been pre-awarded a total of 59.9434 million yuan for multiple State Grid projects, which accounts for 14.49% of its latest audited main business revenue [1] - Tianen Kang's subsidiary received a drug registration certificate for Methimazole tablets, a medication used for hyperthyroidism [2] - Taijing Technology invested 10 million yuan to establish a special fund focused on high-speed network communication chips [3] Group 2 - Youyou Foods plans to use 10 million yuan of its own funds to purchase principal-protected financial products with an expected annual yield of 0.5%-5.0% [4] - Yangfan New Materials announced the release of detention measures against its controlling shareholder, allowing him to resume his duties [5] - Xianju Pharmaceutical received approval for a supplementary application for Nicardipine injection, a calcium channel blocker used for acute hypertension [6] Group 3 - Jingu Co. plans to repurchase shares worth 30-60 million yuan for employee stock ownership plans or equity incentives [7] - Double Tower Foods' Thai subsidiary has completed the construction of its production line and is in the initial production phase [8] - Tongyi Zhong intends to invest approximately 198 million yuan in a project for the industrialization of ultra-high molecular weight polyethylene fibers [9][10] Group 4 - Zhangyue Technology received a dividend of 4.99 million yuan from its stake in Dianzhong Technology, which represents 10.12% of its audited net profit for 2024 [11] - Sihua Electronics announced the resignation of its general manager due to job transfer, with the current manager continuing until a new one is appointed [12] - Jiutian Pharmaceutical's new drug JMHT06 has received approval for clinical trials for acute gouty arthritis [13] Group 5 - Anlian Ruishi has established a joint venture for embodied intelligent robots with a registered capital of 20 million yuan [14] - Kelin Electric's application for a private placement has been accepted by the Shanghai Stock Exchange [15] - Guoyao Modern's subsidiary has received approval for the listing of Agomelatine raw materials, used in antidepressant synthesis [16] Group 6 - Xintiandi's application for the listing of Ferrous Fumarate raw materials has been approved, which is used for treating iron deficiency anemia [17] - ST Weihai, as the leading party, won a bid for a smart agriculture project worth 652 million yuan, accounting for 26.27% of its 2024 audited revenue [18] - Tian Youwei plans to purchase 100% of Krämer Automotive Systems for 1 million euros [19] Group 7 - Guangdong Yuedian A's subsidiary has successfully put into operation the third unit of its Dapu Power Plant project [20] - China Life's total premium exceeded 700 billion yuan as of November 30, 2025 [21] - Shoukai Co. achieved a total signed amount of 15.988 billion yuan in the first 11 months of 2025 [22] Group 8 - Kehua Bio's subsidiary has obtained a medical device registration certificate for an automatic chemiluminescence immunoassay analyzer [23] - Chengyi Pharmaceutical received a drug registration certificate for Torasemide tablets, which have passed the consistency evaluation [24] - Chongqing Construction won a bid for a municipal engineering project worth approximately 1.714 billion yuan [25] Group 9 - Hanjian Heshan signed a procurement contract for pipes worth 388 million yuan [26] - Jiuzhou Pharmaceutical plans to use up to 1 billion yuan of idle raised funds for cash management [27] - Xinwufeng reported an 80.97% year-on-year increase in pig sales in November 2025 [28] Group 10 - Luoniushan reported a 13.57% year-on-year increase in pig sales revenue in November 2025 [29] - Fushilai received a drug registration certificate for Alpha-Lipoic Acid tablets, used for diabetic neuropathy [30] - Dizhe Pharmaceutical presented research data on two innovative drugs at the 67th American Society of Hematology conference [31] - David Medical's subsidiary received two medical device registration certificates for single-use gastric tubes and electronic ureteral endoscope catheters [32]

目前泰国子公司处于初步投产阶段，全面达产尚需一定时间，项目产能的释放需要一个过程。 格隆汇12月9日丨双塔食品(002481.SZ)公布，近日，公司接到泰国子公司通知，泰国子公司生产线项目 已经建成完工，并完成了产品的试生产工作，有关主管部门进行了现场验收，准备投入正常生产。泰国 子公司生产线的投产将进一步增加公司产能、产品市场竞争力和盈利能力，同时对公司未来经营业绩产 生积极的影响，将进一步巩固公司行业优势地位。 ...

烟台双塔食品股份有限公司 近日，公司接到泰国子公司通知，泰国子公司生产线项目已经建成完工，并完 成了产品的试生产工作，有关主管部门进行了现场验收，准备投入正常生产。 泰国子公司生产线的投产将进一步增加公司产能、产品市场竞争力和盈利能力， 同时对公司未来经营业绩产生积极的影响，将进一步巩固公司行业优势地位。 目前泰国子公司处于初步投产阶段，全面达产尚需一定时间，项目产能的释放 需要一个过程，也有可能面临因市场需求环境变化、竞争加剧等因素的影响，敬请 广大投资者关注并注意投资风险。 证券代码：002481 证券简称：双塔食品 编号：2025-079 烟台双塔食品股份有限公司 关于泰国子公司生产线建成投产的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 烟台双塔食品股份有限公司（以下简称"公司"或"本公司"）于 2024 年 5 月 14 日召开第六届董事会第七次会议审议通过《关于对外投资设立控股子公司的 议案》，公司全资子公司双塔食品（香港）有限公司在泰国投资设立控股子公司， 总投资额约 3 亿元人民币（或等额外币），包括设立泰国公司、购买土地、工厂建 设及 ...